FDA Drug Application (202319) for LANSOPRAZOLE by PERRIGO R AND D

Back to FDA Applications sponsored by PERRIGO R AND D

Application Number202319
Product Number001
FormCAPSULE, DELAYED REL PELLETS;ORAL
Dosage15MG
Product Market Status Over The Counter
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLANSOPRAZOLE
Active IngredientLANSOPRAZOLE

Active IngredientCount
List of drugs with Active Ingredient LANSOPRAZOLE9


Back to FDA Applications sponsored by PERRIGO R AND D